Senseonics and its commercial partner Ascensia Diabetes Care have received clearance from the Food and Drug Administration for the first implantable glucose sensor that can
Beta Bionics has announced that it has partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system. The companies plan
Roche plans to roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany in the coming weeks. The company received a CE mark in
Dexcom has revealed that its G6 CGM device is being worn by astronauts as part of the Polaris Dawn mission. The astronauts are wearing the
CeQur has announced recently that the FDA has granted 510(k) clearance for its Simplicity system for an extended wear duration. Simplicity, a wearable, disposable bolus
A UK-wide hospital pilot has paved the way for full NHS access to Abbott and Insulet’s latest diabetes management system for anyone who qualifies for
Abbott has announced that they are partnering with Medtronic Diabetes to connect a continuous glucose monitor (CGM) based on Abbott’s FreeStyle Libre tech with their
New research has found that adult patients with poorly controlled Type 1 diabetes on insulin pumps and continuous glucose monitoring (CGM) systems could benefit from
Medicare will start covering Senseonics’ implantable continuous glucose monitor (CGM) for a broader group of patients from late February. Last year, Medicare updated its policy
Dexcom has announced that it has launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. Dexcom ONE+ uses Dexcom’s established sensor design, with